
51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $400M Post-IPO Equity on 2026-09
Biotechnology • Pharmaceuticals
Tyra Biosciences is a clinical-stage biotechnology company developing precision medicines. It is advancing clinical studies of oral dabogratinib for skeletal dysplasia and urologic cancers.
🔥 3 minutes ago
Where this job comes from
Posted on Tyra Biosciences's careers page ↗, not through a job board
First seen by Remote Rocketship 3 minutes ago

51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $400M Post-IPO Equity on 2026-09
Biotechnology • Pharmaceuticals
Tyra Biosciences is a clinical-stage biotechnology company developing precision medicines. It is advancing clinical studies of oral dabogratinib for skeletal dysplasia and urologic cancers.
• Establish and advance Tyra Biosciences’ medical presence in oncology, focusing on urologic malignancies • Serve as a primary scientific interface between Tyra and the oncology/urology community • Support clinical development, data generation, and pre-commercial readiness for dabogratinib and future pipeline programs • Lead and drive clinical trial and investigator support • Engage investigators and research staff in scientific discussions related to ongoing clinical trials • Identify, develop, and maintain peer-to-peer scientific relationships with KOLs and healthcare professionals • Collect, synthesize, and communicate actionable field insights to internal teams • Identify emerging trends, competitive dynamics, and evolving standards of care in genitourinary oncology/urology • Support scientific data dissemination and medical education initiatives • Execute the scientific engagement plan • Support Tyra’s presence at major oncology and urology congresses • Maintain scientific expertise in oncology and urology • Collaborate with medical affairs, clinical development, clinical operations, and other cross-functional partners • Conduct activities in accordance with regulations and company SOPs • Facilitate problem-solving and conflict resolution with internal and external stakeholders • Work with cross-functional teams to develop, progress, and accelerate program goals • Serve as a role model in problem identification, cross-functional collaboration, and implementation of planned resolutions
• Advanced scientific degree required: MD, PharmD, or PhD • Minimum 5+ years of MSL experience in oncology or urology (preferred) in the biotechnology or pharmaceutical industry, independently managing a large geographic territory • Strong track record of supporting clinical trials in a late-stage or pre-commercial setting • Late-stage oncology drug development (Phase 3) experience required; experience in bladder cancer a plus • Proven track record of effectively networking and building new relationships • Excellent communication and presentation skills • Demonstrated success in advancing drug candidates to development • Ability to provide technical advice and assist with problem resolution • Prior experience working in a small, start-up biotech work environment preferred • Strong analytical and strategic ability • Ability to work independently and to multi-task • Ability to change pace and tasks as needed and to work in a fast-paced environment • Proficient in MS Outlook/Word/Excel/PowerPoint • Must be able to travel extensively (~60-70%), primarily in the U.S. but also internationally as needed
• Competitive base, bonus, new hire and ongoing equity packages • Employer-paid Medical, dental, and vision insurance • Employer-paid life insurance, AD&D, short-term disability, long-term disability, and EAP coverage • 401(k) Plan with a fully vested company match 1:1 up to 4% of contributions • Employee Stock Purchase Plan • 14 -18 paid holidays, including office closure between December 25th and January 1st • Flexible vacation • Sick time • Fitness Program • Get Outdoors Program • Paid parental leave benefit • Tuition assistance
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🕒 Yesterday
Medical Science Liaison advancing Alumis precision medicines for autoimmune diseases. Building Dermatology KOL relationships, supporting trials, and informing medical strategy.
🕒 2 days ago
Regional MOSL at AbbVie, which develops innovative medicines, advancing outcomes-focused scientific engagement with healthcare decision makers. Integrating clinical evidence, health economics, and real-world evidence to inform access.
🕒 2 days ago
AbbVie Regional MOSL guiding outcomes-focused scientific engagement with regional healthcare decision makers. Integrating clinical evidence, real-world data, and health economics to inform access planning.
🕒 2 days ago
Regional Medical Outcomes Science Liaison at AbbVie, advancing evidence-based engagement with healthcare decision makers. Integrating clinical, real-world, and health economics evidence to improve patient access.
🕒 2 days ago
AbbVie Regional MOSL advancing outcomes-focused scientific engagement with healthcare decision makers. Integrating clinical evidence, health economics, and real-world data to support access planning.